Distinct Transcriptional Profiles of Adrenocortical Tumors Uncovered by DNA Microarray Analysis-Reference-Cited by-同舟云学术

Distinct Transcriptional Profiles of Adrenocortical Tumors Uncovered by DNA Microarray Analysis

Published:2003-02 Issue:2 Volume:162 Page:521-531
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Giordano Thomas J.,Thomas Dafydd G.,Kuick Rork,Lizyness Michelle,Misek David E.,Smith Angela L.,Sanders Donita,Aljundi Rima T.,Gauger Paul G.,Thompson Norman W.,Taylor Jeremy M.G.,Hanash Samir M.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference66 articles.

1. Adrenocortical carcinoma;Brennan;CA Cancer J Clin,1987

2. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors;Weiss;Am J Surg Pathol,1984

3. Pathologic features of prognostic significance in adrenocortical carcinoma;Weiss;Am J Surg Pathol,1989

4. The expression of inhibin/activin subunits in the human adrenal cortex and its tumours;Munro;J Endocrinol,1999

5. Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin;McCluggage;J Clin Pathol,1998

Cited by 316 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression Patterns of MOTS-c in Adrenal Tumors: Results from a Preliminary Study;International Journal of Molecular Sciences;2024-08-09

2. Current Status and Future Direction in the Treatment of Advanced Adrenocortical Carcinoma;Current Oncology Reports;2024-02-21

3. High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study;International Journal of Molecular Sciences;2023-11-21

4. A 3D adrenocortical carcinoma tumor platform for preclinical modeling of drug response and matrix metalloproteinase activity;Scientific Reports;2023-09-19

5. A 3D adrenocortical carcinoma tumor platform for preclinical modeling of drug response and matrix metalloproteinase activity;2023-01-25